February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and survivorship lung health.
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...
Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
Suchan still needed chemotherapy and radiation, but Salgia credits Rybrevant for shrinking her tumors 60 to 70%. It specifically targets her cancer cells and revs up the immune system. For a year and ...
Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is a well-recognized cause of bacterial pneumonia, resulting in increased morbidity and mortality worldwide. Traditional antibiotics face ...
Hernexeos is the second drug to secure an FDA approval under the agency’s priority voucher scheme, following in the footsteps of USAntibiotics’ Augmentin XR, which was granted the ticket in December ...
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results